Capricor Therapeutics, Inc.
CAPR· Nasdaq
Released Mar 12, 2026, after the close
10-K filed Mar 17, 2026, 76 days after period end · 0001104659-26-029580
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $11.13M | $12.09M | — |
| Net Income | -$30.17M |
Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR
| -$7.12M |
| -$762.09K |
| -$7.72M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.